// App-Quantinova.ai

MON-291 : EVALUATION OF CARDIOVASCULAR RISK AND ASSOCIATION WITH NOVEL BIOMARKERS ON PATIENTS WITH TYPE 2 DIABETES MELLITUS

Researchers

Presenter

  • G. Da Silva Jr.

Principal Investigators

  • A.K. M. Neri

  • G. C. Meneses

  • S. Fraser

  • A. M.C. Martins

  • E. F. Daher

  • R. L. Alencar

  • R. P. Silva

Medical Centers

  • University of Fortaleza, School of Medicine, Fortaleza, Brazil

  • Federal University of Ceara, School of Medicine, Fortaleza, Brazil

  • Federal University of Ceara, Pharmacology Post-Graduation Program, Fortaleza, Brazil

  • University of Southampton, Academic Unit of Primary Care and Population Sciences, Southampton, United Kingdom

  • Federal University of Ceara, Medical Sciences Post-Graduation Program, Fortaleza, Brazil

Locations

  • Brazil

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Urology

  • Endocrine/metabolic Diseases (ME)

  • Genetic Disorder

  • Nephrology

Disease

  • Type 2 diabetes mellitus

  • Microalbuminuria

  • Diabetes

Biomarkers

  • Hepatitis A virus cellular receptor 1

  • Fibroblast growth factor 23

  • Vascular cell adhesion molecule 1

  • Vascular endothelial growth factor A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cross-Sectional

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved